AKUMS existing six state-of-the-art manufacturing facilities have huge per day capacity to produce formulations in practically all dosage forms, i.e. Tablets, Capsules, Soft gels, Dry Syrups, Liquid Orals, Powder in Sachet, Dry & Liquid Injections, Pre-filled Syringes, Large Volume Parenterals (up to 100 ml), Lyophilized Injections and Eye / Ear / Nasal Drops in FORM FILL & SEAL and THREE PIECE Packs.
AKUMS first Plant, commissioned in the year 2004 is the State-of-the-Art manufacturing facility producing tablets, capsules, soft - Gelatin capsules & Dry Syrups with huge PER DAY manufacturing capacity in all sections and has separate blocks for Beta Lactums, Non-Beta Lactums, Cephalosporin & Penicillin preparations.
AKUMS first Plant, commissioned in the year 2004 is the State-of-the-Art manufacturing facility producing tablets, capsules, soft - Gelatin capsules & Dry Syrups with huge PER DAY manufacturing capacity in all sections and has separate blocks for Beta Lactums, Non-Beta Lactums, Cephalosporin & Penicillin preparations.
Location: India, Delhi
Employees: 10001+
Phone: 011 4751 1000
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Quadria Ca... | quadriacap... |
Mentions in press and media 2
| Date | Title | Description |
| 11.11.2024 | Akums Q2 PAT at ₹67 cr | Akums Drugs and Pharmaceuticals Ltd, one of the largest contract development and manufacturing organisation (CDMO) in India, reported an adjusted PAT of ₹67 crore, up 9 per cent y-o-y for quarter ending September 30, 2024. Adjusted PAT in t... |
| 27.08.2024 | Akums Drugs and Pharmaceuticals back in black with ₹42 crore standalone net profit for June quarter | Akums Drugs and Pharmaceuticals Ltd reported a standalone net profit of ₹42 crore for the quarter ending June 30, 2024; as against a net loss of ₹19 crore in the year-ago-period. The company reported a revenue of ₹317 crore for the period u... |